Description
An effective, veterinary strength medicine with active ingredients, Beaphar Anti Parasite Spot On is suitable for all small animals weighing between 50-300g, including hamsters, gerbils, rats, mice and small guinea pigs, providing complete anti-parasite animal protection.
A UK-authorised veterinary medicine with ivermectin, Beaphar Anti Parasite Spot On effectively and quickly kills parasites, including fleas, lice, mange mites, other mites and roundworms. Containing 2 pipettes per pack, providing appropriate dosage for pets weighing between 350-300g in weight, it is an easy to use spot on treatment, controlling parasites on small animals for up to 4 weeks. It is recommended that you treat all pets in the cage at the same time, treating the environment with a suitable insecticide for full parasite protection.
- UK-authorised veterinary medication
- With Ivermectin, an active ingredient effectively killing parasites
- Suitable for all small animals between 50-300g, including hamsters, gerbils, mice, rats and small guinea pigs
- Effectively treats fleas, lice, mange mites, other mites and roundworms
- Easy-to-use spot on treatment
- 2 pipettes per pack
How to Use: Weigh your pet carefully before application and use the following table to calculate the correct dosage. See gallery for guidance and instruction.
For larger pets weighing over 300g, you would require Beaphar Anti Parasite Spot On for Rabbits, Guinea Pigs, Ferrets and Rats 4pk.
Active Ingredients: Ivermectin 25ug
EAN: 8711231153411
Always read safety instructions, leaflets and/or packaging before use. While every care is taken to ensure product images, nutritional information and stated features are correct, these may vary slightly depending on manufacturer changes. Should you have any concerns regarding use or effectiveness of this product, please contact the manufacturer directly. Always ensure access to clean, fresh water for your pet and discard any damaged or defective items to keep your pet safe and healthy.
Reviews
There are no reviews yet.